Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study

1. Diaz, L.A.
2. Shiu, K.-K.
3. Kim, T.-W.
4. Jensen, B.V.
5. Jensen, L.H.
6. Punt, C.
7. Smith, D.
8. Garcia-Carbonero, R.
9. Benavides, M.
10. Gibbs, P.
11. de la Fourchardiere, C.
12. Rivera, F.
13. Elez, E.
14. Le, D.T.
15. Yoshino, T.
16. Zhong, W.Y.
17. Fogelman, D.
18. Marinello, P.
19. Andre, T.